<DOC>
	<DOCNO>NCT00604799</DOCNO>
	<brief_summary>A Descending Thoracic Aneurysm bulge aorta . The aorta large blood vessel carry blood away heart organs rest body . Your aneurysm cause weaken artery wall . If leave untreated , bulge may continue grow large may ultimately rupture ( break open ) extend size seriously affect major artery area . In Research Study device place inside aorta block weaken part artery wall circulatory system . Information collect performance device 5 year .</brief_summary>
	<brief_title>VALOR : The Talent Thoracic Stent Graft System Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>Talent Captivia Inclusion Criteria 1 . Patient least 18 year age . 2 . Patient surgical nonsurgical candidate 3 . Patient : 1 . Fusiform focal TAA AND / OR 2 . Focal saccular TAA penetrate atherosclerotic ulcer . 4 . Subject 's anatomy must meet follow anatomical criterion : 1. iliac/femoral access vessel morphology compatible vascular access technique , device , and/or accessory 2. nonaneurysmal aortic diameter range 1842mm ; 3. nonaneurysmal aortic proximal distal neck length =/ &gt; 20mm 5 . Thoracic aortic lesion confirm , minimum , diagnostic contrast enhance computerized tomography ( CTA ) optional 3D reconstruction , and/or contrast enhance Magnetic Resonance Angiogram ( MRA ) obtain within previous three ( 3 ) month prior implant procedure . 6 . Subject subject 's legal representative understands sign Informed Consent approve Sponsor IRB study . 7 . Patient must able willing undergo followup image examination postoperatively 6 month . Talent Captivia Exclusion Criteria 1 . Planned placement COVERED ( top edge fabric ) portion stent graft require implant occur zone 0 1 2 . Pregnant female 3 . Patient connective tissue disease ( e.g Marfan 's syndrome , medial degeneration ) . 4 . Patient mycotic aneurysm suspect systemic infection . 5 . Patient history bleed diathesis , coagulopathy , refuse blood transfusion . 6 . Patient currently participate investigational drug device clinical trial would interfere Talent Captivia protocol endpoint followup . 7 . The patient know allergy intolerance device component . 8 . The patient know hypersensitivity contraindication anticoagulant contrast medium , amenable pretreatment . 9 . The patient another medical condition , may cause noncompliant protocol , confound data interpretation , limited life expectancy le 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>